Jibin Liu

1.3k total citations · 1 hit paper
54 papers, 753 citations indexed

About

Jibin Liu is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jibin Liu has authored 54 papers receiving a total of 753 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 20 papers in Cancer Research and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jibin Liu's work include Cancer-related molecular mechanisms research (12 papers), RNA modifications and cancer (12 papers) and MicroRNA in disease regulation (9 papers). Jibin Liu is often cited by papers focused on Cancer-related molecular mechanisms research (12 papers), RNA modifications and cancer (12 papers) and MicroRNA in disease regulation (9 papers). Jibin Liu collaborates with scholars based in China, United States and Hong Kong. Jibin Liu's co-authors include Yu‐Shui Ma, Da Fu, Wen Li, Jing Deng, Jiang Geng, Likun Hou, Haimin Lu, Jie Zhang, Chunyan Wu and Sun Feng and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and ACS Applied Materials & Interfaces.

In The Last Decade

Jibin Liu

47 papers receiving 746 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Liquid biopsy in lung cancer: significance in diagnostics, prediction, and treatment monitoring

2022 269 citations Jibin Liu, Likun Hou et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jibin Liu China	13	438	295	164	158	73	54	753
Haohai Zhang China	17	372 0.8×	291 1.0×	130 0.8×	201 1.3×	61 0.8×	27	784
Yunhua Xu China	16	601 1.4×	389 1.3×	264 1.6×	215 1.4×	82 1.1×	36	921
Erwan Pencreach France	17	323 0.7×	248 0.8×	200 1.2×	350 2.2×	54 0.7×	35	797
Xigan He China	12	459 1.0×	327 1.1×	114 0.7×	125 0.8×	46 0.6×	28	706
Xiaoguang Sun China	13	351 0.8×	317 1.1×	117 0.7×	167 1.1×	42 0.6×	19	756
Sufang Wu China	18	484 1.1×	325 1.1×	85 0.5×	103 0.7×	70 1.0×	39	725
Yajin Chen China	15	550 1.3×	340 1.2×	165 1.0×	235 1.5×	99 1.4×	43	959
Emmanuelle Gormally France	10	338 0.8×	327 1.1×	96 0.6×	176 1.1×	63 0.9×	15	710

Countries citing papers authored by Jibin Liu

Since Specialization

Citations

This map shows the geographic impact of Jibin Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jibin Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jibin Liu more than expected).

Fields of papers citing papers by Jibin Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jibin Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jibin Liu. The network helps show where Jibin Liu may publish in the future.

Co-authorship network of co-authors of Jibin Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Jibin Liu. A scholar is included among the top collaborators of Jibin Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jibin Liu. Jibin Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Xiyue, Yuqing Dong, Shuqing Yu, et al.. (2025). Antithrombotic Effect of Chenopodium album L. Extract and Its Fractions via Regulating TLRs and the Downstream MAPKs and PI3K/AKT Signaling Pathways in Zebrafish. International Journal of Molecular Sciences. 26(5). 2118–2118. 1 indexed citations

Yu, Haixia, Shucheng Xu, Zhenshun Song, et al.. (2025). Enhancing the electrochemical performance of Prussian blue analogue cathodes through mild heat treatment for sodium-ion batteries. New Journal of Chemistry. 49(27). 11574–11578. 2 indexed citations

Li, Yuanyuan, Yumeng Wu, Wenjing Zhao, et al.. (2025). GRWD1 inhibits nucleolar stress and reduces the sensitivity of hepatocellular carcinoma to oxaliplatin. Genes & Diseases. 13(2). 101725–101725.

Li, Dong, Xinhui Huang, Yao Chen, et al.. (2025). Natural products targeting ubiquitination to combat kidney fibrosis. Future Journal of Pharmaceutical Sciences. 11(1).

Wang, Yaxuan, et al.. (2025). Understanding the relationship between cuproptosis and the development of hepatocellular carcinoma: implications for targeted therapies. Frontiers in Immunology. 16. 1557223–1557223. 4 indexed citations

Zhang, Jie, et al.. (2024). Can Omega-3 prevent the accidence of stroke: a mendelian randomization study. Hereditas. 161(1). 30–30. 1 indexed citations

Liu, Shu, et al.. (2024). Effect of SiHuangQingXinWan on Klebsiella pneumoniae-induced pneumonia: mechanistic insights. Frontiers in Pharmacology. 15. 1444439–1444439.

Zhang, Chengchen, Jibin Liu, Jun Wu, et al.. (2024). Key molecular DNA damage responses of human cells to radiation. Frontiers in Cell and Developmental Biology. 12. 1422520–1422520. 4 indexed citations

Jin, Xing, Lei Liu, Dan Liu, et al.. (2024). Unveiling the methionine cycle: a key metabolic signature and NR4A2 as a methionine-responsive oncogene in esophageal squamous cell carcinoma. Cell Death and Differentiation. 31(5). 558–573. 11 indexed citations

10.

Li, Sha, Pei Xue, Kun Ye, et al.. (2023). Identification and validation of functional roles for three MYC-associated genes in hepatocellular carcinoma. Journal of Advanced Research. 54. 133–146. 12 indexed citations

11.

Zhu, Sha, et al.. (2023). Surmounting Cancer Drug Resistance: New Perspective on RNA-Binding Proteins. Pharmaceuticals. 16(8). 1114–1114. 4 indexed citations

12.

Liu, Jibin, et al.. (2022). Current Status and Prospects of Clinical Treatment of Osteosarcoma. Technology in Cancer Research & Treatment. 21. 2213866584–2213866584. 42 indexed citations

13.

Wu, Yumeng, Biao Wu, Xuming Wu, et al.. (2022). Pan‐Cancer Analysis Predicts the Immunological and Prognostic Role of ZC3H12C in KIRC. BioMed Research International. 2022(1). 4541571–4541571. 2 indexed citations

14.

Wu, Yumeng, Cheng Shen, Xinghui Wang, et al.. (2022). Development and Validation of a Novel Circadian Rhythm‐Related Signature to Predict the Prognosis of the Patients with Hepatocellular Carcinoma. BioMed Research International. 2022(1). 4263261–4263261. 4 indexed citations

15.

Wu, Biao, Yumeng Wu, Yuanyuan Li, et al.. (2021). An Integrative Pan‐Cancer Analysis of the Oncogenic Role of COPB2 in Human Tumors. BioMed Research International. 2021(1). 7405322–7405322. 4 indexed citations

16.

Wu, Yumeng, Xuming Wu, Wenjing Zhao, et al.. (2021). Comprehensive Analysis of Glutamate‐Rich WD Repeat‐Containing Protein 1 and Its Potential Clinical Significance for Pancancer. BioMed Research International. 2021(1). 8201377–8201377. 6 indexed citations

17.

Tian, Linlin, Bin Qian, Xiaohui Jiang, et al.. (2021). MicroRNA-497-5p Is Downregulated in Hepatocellular Carcinoma and Associated with Tumorigenesis and Poor Prognosis in Patients. International Journal of Genomics. 2021. 1–16. 12 indexed citations

18.

Ma, Yu‐Shui, Bowen Shi, Haimin Lu, et al.. (2021). MicroRNA-499 serves as a sensitizer for lung cancer cells to radiotherapy by inhibition of CK2α-mediated phosphorylation of p65. Molecular Therapy — Oncolytics. 21. 171–182. 4 indexed citations

19.

Huang, Mingde, Yao Liu, Li Liu, et al.. (2014). A genetic variant in pseudogene E2F3P1 contributes to prognosis of hepatocellular carcinoma. Journal of Biomedical Research. 28(3). 194–194. 15 indexed citations

20.

Zhang, Yixin, Xiaoying Wang, Jibin Liu, Suqing Zhang, & Yiren Chen. (2008). [Effects of auto-tumor infiltrating lymphocytes induced by interleukin (IL)-12 with IL-2 on patients of primary hepatic carcinoma].. PubMed. 88(14). 973–6. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Haohai Zhang Breakdown of academic impact, for papers by Yunhua Xu Breakdown of academic impact, for papers by Erwan Pencreach Breakdown of academic impact, for papers by Xigan He Breakdown of academic impact, for papers by Xiaoguang Sun Breakdown of academic impact, for papers by Sufang Wu Breakdown of academic impact, for papers by Yajin Chen Breakdown of academic impact, for papers by Emmanuelle Gormally